Analyst Ratings for Neurocrine Bio. (NBIX)
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $200.00 (Oppenheimer)
- Lowest: $100.00 (BMO Capital)
- Average: $144.29
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$144.29 (+4.6%)
* Over Last 12-Mos
Rating Score: 7.3 / 10 Percentile Rank: 78%
Rating Score: 7.3 / 10 Percentile Rank: 78%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/13/2023 | William O'Neil | N/A | New Coverage | Buy (N/A) |
N/A (N/A) |
118.51 (137.92) |
16.38% | Details |
12/13/2023 | Citi | David Hoang | New Coverage | Neutral (N/A) |
127.00 (N/A) |
118.51 (137.92) |
16.38% | Details |